This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Insulin and Injectable Therapy:  Posters and Abstracts from San Diego

Insulin and Injectable Therapy: Posters and Abstracts from San Diego

Format

Webcast

Time to Complete

2.50 hours

Released

July 31, 2017

Expires

July 30, 2018
Add to Queue


Maximum Credits

2.50 / AMA PRA Category 1 CreditTM
2.50 / ANCC Contact Hours

Accredited Provider

Provided by the Annenberg Center for Health Sciences at Eisenhower

Commercial Supporter

Supported by an educational grant from Novo Nordisk Inc.

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Program Description

Mayer Davidson, MD, and Vivian Fonseca, MD, provide their perspectives on the clinical importance of 10 posters presented at the 77th Scientific Sessions of the American Diabetes Association from June 9-13, 2017. Drs. Davidson and Fonseca summarize the latest research developments on key mechanisms in the pathogenesis of type 2 diabetes mellitus and how they are modified by basal and prandial insulins and glucagon-like peptide-1 receptor agonists. In addition, Drs. Davidson and Fonseca provide their insight into the clinical implications of clinical trial results regarding the efficacy, safety, and tolerability of recently available and investigational injectable medications for diabetes mellitus.

Intended Audience

This activity was developed for endocrinologists, primary care physicians, physician assistants, nurse practitioners, nurses, and other healthcare providers who wish to improve the care they provide to persons with type 1 or type 2 diabetes.

Educational Objectives

At the conclusion of this activity, participants should be better able to:

  • Summarize the latest research developments in the treatment of type 1 and type 2 diabetes with insulin and other injectable therapies
  • Incorporate evidence-based research into clinical practice

Conflict Of Interest Disclosure Policy

The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

Faculty

Mayer Davidson, MD
Professor of Medicine
Charles R. Drew University
David Geffen School of Medicine
University of California, Los Angeles
Los Angeles, CA

Dr. Davidson has no significant relationships to disclose.

Vivian Fonseca, MD
Professor of Medicine and Pharmacology
Tullis-Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA

Dr. Fonseca discloses the following:
Research Support: Asahi, Bayer
Consultant: AstraZeneca, Eli Lilly, Intarcia, Novo Nordisk, Sanofi Aventis, Takeda

Planners and Managers Disclosures

Annenberg Center for Health Sciences
John Bayliss, VP
, Business Development, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Additional content planners:
Gene Cullen, MD
(peer reviewer): No significant relationships to disclose
Greg Scott, PharmD (medical writer): No significant relationships to disclose
Sally Schermer, BSN, MBA (lead nurse planner): No significant relationships to disclose

Credit

2.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.50 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

2.50

Type

CNE Contact Hour(s)

Accreditation Statement

The Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

A maximum of 2.50 contact hours may be earned for successful completion of this activity.

Disclosure of Unlabeled Use

It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.

The faculty for this activity has disclosed that there will be no discussion about the use of products for non-FDA approved indications.

Disclaimer

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

Instructions

Please note: The content of this activity is housed on the website of our educational partner, Annenberg Center for Health Sciences at Eisenhower, and requires you to leave myCME and register on the Annenberg website.

Your certificate will be saved on the Annenberg website only and cannot be accessed in your myCME CME History. Please go to https://education.annenberg.net and sign in to access your certificate in the future.

Contact Information

For help or questions about this Internet activity, please contact Annenberg Continuing Education:
ce@annenberg.net
Annenberg Center for Health Sciences
39000 Bob Hope Drive
Dinah Shore Building
Rancho Mirage, CA 92270
Phone: 760-773-4500
Fax: 760-773-4513
8 AM – 5 PM, Pacific Time, Monday – Friday

Privacy Policy

Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us, or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at http://www.annenberg.net/privacy-policy/

myCME privacy policy
Add to Queue